NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-154-2010-1-NL-13 Chimpanzee Adenoviral Vector-Based Filovirus Vaccines NL EP 11769662.5 Issued
NIAID E-059-2004-0-US-04 Multimeric Protein Toxins To Target Cells Having Multiple Identifying Characteristics US DIV 13/088,011 8388933 Expired PDF
NIAID E-154-2010-1-PCT-01 Chimpanzee Adenoviral Vectors Based Filovirus Vaccines PCT PCT COMB PCT/US2011/032682 Expired
NCI E-122-2010-0-PCT-02 Methods To Detect And Isolate Cancer Stem Cells PCT PCT PCT/US2011/032748 Abandoned
NCI E-174-2010-1-PCT-02 MicroRNA Hsa-miR-17 For Diagnosing And Treating Fibrotic Diseases PCT PCT PCT/DK11/000028 Abandoned
NIDCR E-087-2011-0-US-01 AAV Mediated CTLA-4 Gene Transfer to Treat Sjogren's Syndrome US 61/476,168 Abandoned
NIDCR E-140-2011-0-US-01 Differentially-Expressed Gene Products For Use In The Diagnosis And Treatment of Sjogren's Syndrome US 61/476,192 Abandoned
NIAID E-335-2003-2-US-01 HIV Vacccines Based on ENV of Multiple Clades Of HIV US DIV 13/086,884 8323961 Abandoned PDF
NCATS E-109-2010-0-PCT-02 Arylthiazolyl Piperidines And Related Compounds As Modulators Of Survival Motor Neuron (SMN) Protein Production PCT PCT PCT/US11/32501 Expired
NCATS E-109-2010-0-EP-05 Arylthiazolyl Piperidines And Related Compounds As Modulators Of Survival Motor Neuron (SMN) Protein Production EP National Stage 11717406.0 Abandoned
NCATS E-221-2011-0-US-01 Discovery Of New Antimalarial Chemotypes Through Chemical Methodology And Library Development US 61/475,482 Abandoned
NINDS E-050-2011-0-US-01 Isoindoline Compounds For The Treatment Of Spinal Muscular Atrophy (SMA) And Other Uses US 61/475,541 Abandoned
NIA E-146-1993-0-US-55 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US CON 13/086,277 Abandoned
NCI E-139-2010-0-PCT-02 Biomarkers for Hepatocellular Cancer PCT PCT PCT/US2011/032285 Abandoned
NICHD E-124-2008-0-US-04 Compounds And Methods For The Treatment of Viral Infection US National Stage 12/934,769 8946243 Issued PDF
NCI E-161-2008-0-US-03 Antiviral Activity Of The Protein Scytovirin (SVN) AND Methods Of Use US National Stage 13/056,892 Abandoned
NCI E-068-2011-0-US-01 Human Monoclonal Antibodies That Bind Insulin-like Growth Factor (IGF) I And II US 61/474,664 Abandoned
NIAMS E-128-2010-1-US-01 TNFalpha-mediated Cleavage And Inactivation Of SIRT1 In Human Chondrocytes US 61/474,351 Abandoned
NCI E-181-2009-3-US-01 Peptide Mimetic Ligands Of Polo-like Kinase 1 Polo Box Domain And Methods of Use US 61/474,621 Abandoned
NIAID E-145-2011-0-US-01 Plasmodial Surface Anion Channel Inhibitors For The Treatment of Malaria US 61/474,583 Abandoned
NCI E-322-2008-0-US-03 Method of Making A Vaccine US National Stage 13/123,659 Abandoned
NICHD E-167-2009-2-US-01 Cholesterol Therapy For Autistic Spectrum Disorder US 61/473,993 Abandoned
NIDDK E-067-2010-0-AU-03 Inverse Agonists And Neutral Antagonists For the TSH Receptor AU National Stage 2011237421 Abandoned
NIDDK E-067-2010-0-CN-05 Inverse Agonists And Neutral Antagonists For the TSH Receptor CN National Stage 201180013235.9 Abandoned
NIDDK E-219-2011-2-US-02 CLINICAL DECISION MODEL US National Stage 13/083,184 8510245 Issued PDF
NIDDK E-067-2010-0-EP-06 Inverse Agonists And Neutral Antagonists For the TSH Receptor EP National Stage 11766807.9 Abandoned
NIDDK E-067-2010-0-PCT-02 Inverse Agonists And Neutral Antagonists For the TSH Receptor PCT PCT PCT/US2011/031752 Expired
NIDDK E-067-2010-0-CA-04 Inverse Agonists And Neutral Antagonists For the TSH Receptor CA National Stage 2789818 Abandoned
CC E-090-2011-0-US-01 Thrombolytic Temperature-sensitive Liposomes US 61/473,665 Abandoned
NICHD E-157-2011-0-US-01 Small Molecule (Derivatives Of Hydroxylamine) Therapeutic Compounds Targeting Thioesterase Deficiency Disorders And Methods of Using The Same US 61/473,692 Abandoned
NIAID E-150-2011-0-US-01 Ubiquitin Fusions For Improving The Efficacy Of Cytosolic Acting Targeted Toxins US 61/473,450 Abandoned
NCI E-148-2011-0-US-01 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer US 61/473,409 Abandoned
NINDS E-129-2011-0-US-01 BO-based Modulation Of Bl Excitation In MRI US 61/473,610 Abandoned
NCI E-268-2012-0-DE-01 Niclosamide for the treatment of cancer metastasis DE ORD 11162875.6 Pending
NIDDK E-067-2010-0-IN-07 Inverse Agonists And Neutral Antagonists For the TSH Receptor IN National Stage 2055/KOLNP/2012 Abandoned
NCI E-131-2011-0-US-01 Nitric Oxide Releasing Non-Steroidal Anti-Inflammatory Compounds And Uses Thereof In The Treatment And Prevention Of Diseases Or Disorders US 61/472,770 Abandoned
NCI E-281-2009-0-PCT-02 Diagnosis And Treatment of Cancer Through An NUAK2 Assessment and Modulation PCT PCT PCT/US2011/031483 Abandoned
NIA E-251-1997-0-JP-29 DIFFERENTIATION OF NON-INSULIN PRODUCING CELLS INTO INSULIN PRODUCING CELLS BY GLP-1 OR EXENDIN-4 AND USES THEREOF JP DIV 2011-083828 Abandoned
NCI E-200-2011-2-US-01 METHODS OF TREATING LYMPHOCYTIC LEUKEMIA USING INHIBITORS OF BRUTON'S TYROSINE KINASE US 61/472,138 Abandoned
NCI E-010-2008-0-US-03 METHODS AND COMPOSITIONS FOR PROTEIN DELIVERY US National Stage 13/122,513 9296790 Issued PDF
NCI E-272-1998-0-US-05 TUMOR SUPPRESSOR GENE p33ING2 US DIV 13/079,743 8206937 Abandoned PDF
NCI E-149-2011-0-US-01 Design, Generation, And Characterization Of A Monoclonal Antibody Against The NADPH Oxidase 5 (NOX5) Protein US 61/471,596 Abandoned
NIAID E-005-2009-1-US-02 Flavivirus-based System For Production Of Hepatitis C Virus (HCV) US National Stage 13/122,154 9052321 Issued PDF
NICHD E-042-2013-0-CA-05 Injectable Dendrimer Hydrogel Nanoparticles CA National Stage 2830052 Issued
NCI E-116-2001-0-HK-38 Formulation of Boronic Acid Compounds HK EP 11103293.5 Expired
NIAID E-019-2007-2-US-10 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS US CON 13/077,488 8580277 Abandoned PDF
NICHD E-042-2013-0-PCT-02 Injectable Dendrimer Hydrogel Nanoparticles PCT PCT PCT/US2011/030648 Expired
NICHD E-042-2013-0-EP-04 Injectable Dendrimer Hydrogel Nanoparticles EP National Stage 11763407.1 Abandoned
NCI E-181-2006-0-US-09 MicroRNA-based Methods and Compositions for the Diagnosis, Prognosis, And Treatment of Lung Cancer using Mir-17-3P US DIV 13/075,828 8377637 Abandoned PDF
NCI E-181-2006-0-US-10 MicroRNA-Based Methods And Compositions For the Diagnosis, Prognosis, and Treatment of Lung Cancer Using MIR-21 US DIV 13/075,820 8361710 Abandoned PDF